Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALB-AVB Trial: Albumin in Acute Variceal Bleeding
NCT07395141Phase 3Not yet recruiting
- Sponsor
- King George's Medical University
- Start
- Mar 2026
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human) in Variceal bleeding, Cirrhosis, sponsored by King George's Medical University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
albumin (human)
03
Conditions
Variceal bleedingCirrhosis
Beyond the preview
Go deeper on NCT07395141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07395141.